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Background: Limb injuries comprise 50-60% of U.S. Service member’s casualties of wars in Afghanistan and
Iraq. Combat-related vascular injuries are present in 12% of this cohort, a rate 5 times higher than in prior wars.
Improvements in medical and surgical trauma care, including initial in-theatre limb salvage approaches (IILS)
have resulted in improved survival and fewer amputations, however, the long-term outcomes such as morbidity,
functional decline, and risk for late amputation of salvaged limbs using current process of care have not been
studied. The long-term care of these injured warfighters poses a significant challenge to the Department of
Defense (DoD) and Department of Veterans Affairs (VA).
Methods/Design: The VA Vascular Injury Study (VAVIS): VA-DoD Extremity Injury Outcomes Collaborative, funded
by the VA, Health Services Research and Development Service, is a longitudinal cohort study of Veterans with
vascular extremity injuries. Enrollment will begin April, 2015 and continue for 3 years. Individuals with a validated
extremity vascular injury in the Department of Defense Trauma Registry will be contacted and will complete a set
of validated demographic, social, behavioral, and functional status measures during interview and online/ mailed
survey. Primary outcome measures will: 1) Compare injury, demographic and geospatial characteristics of patients
with IILS and identify late vascular surgery related limb complications and health care utilization in Veterans receiving
VA vs. non-VA care, 2) Characterize the preventive services received by individuals with vascular repair and related
outcomes, and 3) Describe patient-reported functional outcomes in Veterans with traumatic vascular limb injuries.
Discussion: This study will provide key information about the current process of care for Active Duty Service members
and Veterans with polytrauma/vascular injuries at risk for persistent morbidity and late amputation. The results of this
study will be the first step for clinicians in VA and military settings to generate evidence-based treatment and care
approaches to these injuries. It will identify areas where rehabilitation medicine and vascular specialty care or telehealth
options are needed to allow for better planning, resource utilization, and improved DoD-to-VA care transitions.
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Combat-related vascular injuries
Wartime injuries have been studied during every major
conflict of the 20th and 21st centuries. Hughes in Korea
[1], and Rich in Vietnam [2], each advanced the care of
Service members with vascular injuries. Ligation of
injured blood vessels and the resultant high limb loss
rate in World War II gave way to arterial and venous
repair in the Korean and Vietnam Wars. With these
advances, life and limb salvage rates improved dramatically
in the short and mid-term time frame. However, long term
outcomes following the definitive repair of wartime
vascular injuries by a vascular specialist in the theater
of war have not previously been evaluated. To improve
care, we must provide long term follow up and define the
natural history of wartime vascular injury over an injured
Soldier’s lifetime.
Improvements in battlefield protection devices,
casualty evacuation and medical care have enhanced
survival rates, currently over 90%, following combat
injuries. Many survivors of once-lethal injuries now
require prolonged medical and rehabilitation care for
polytrauma injuries [3]. Rapid aero-medical evacuation
from the battlefield to definitive surgical care has been a
major contributor to improved initial limb salvage rates,
allowing access to vascular surgery care more rapidly,
thereby decreasing ischemia times of injured limbs. The
in-theatre use of diagnostic angiography and endovascular
treatments has enabled more attempts at limb salvage
after extremity vascular injury [4]. Additionally, patients
usually leave the theater of war within 24 hours after
receiving initial medical treatment [4-6]. Subsequent care
is obtained in several locations while en route to the
United States, and in military trauma centers in the U.S.
Once the acute hospitalization phase is completed, and
longer term rehabilitation at Walter Reed National Military
Medical Center or the San Antonio Military Medical
Center is completed, the patient will be released to the
home station and the associated military treatment facility
(MTF) or to the local community. In the event that the
Service member separates from the DoD, care is often
transferred to the Veterans Administration (VA), espe-
cially when high service-connected ratings of disability
are present. Most of the MTFs do not have a vascular
surgeon or non-invasive vascular laboratory (duplex
ultrasound) to provide long-term surveillance of the
vascular repair.
Prospective and retrospective studies of orthopaedic and
vascular injury are limited
The Lower Extremity Assessment Project (LEAP) was a
prospective, longitudinal study performed at 8 level 1
civilian trauma centers to study the outcomes of lower
extremity orthopaedic trauma to answer the questionssurrounding the decision to amputate or salvage injured
limbs [7]. While there were no controls for the therapeutic
interventions, long-term follow up of 7 years is available
on most patients. The results of multiple studies emanating
from this trial are reviewed in Higgins et al. [7] Major find-
ings include similar self-reported health status measures
2 years after injury in patients undergoing amputation com-
pared to limb reconstruction. However, patients with limb
reconstruction had a higher rate of complications and
rehospitalization [8]. While two year health care costs were
similar between patients with limb salvage and amputation,
prosthesis-related expenses increased the costs for patients
with amputations and the projected lifetime health care
costs were three times higher for patients with amputation
compared to limb salvage [9]. None of the lower extremity
injury severity indices have been shown to be sensitive
predictors of which patients should undergo initial amputa-
tion versus limb reconstruction [7]. The only study that
focused on vascular injuries was in association with knee
dislocation; this study contained 18 patients and suggested
that outcomes in revascularized patients were better than
those undergoing amputation [10].
The Military Extremity Trauma Amputation/Limb
Salvage (METALS) study applied methods similar to those
in the LEAP study to the Operation Enduring Freedom/
Operation Iraqi Freedom/Operation New Dawn (OEF/
OIF/OND) military population [11]. This retrospective
cross-sectional study included 324 U.S. Service members
who had sustained major lower limb trauma as a result of
high-energy blast and ordnance-related mechanisms. Both
unilateral and bilateral lower limb traumatic injuries were
included. Clinical data were obtained from participants’
medical records and through telephone interviews.
Patients in the limb salvage and amputation groups reported
significant disability compared to normal populations and
38% screened positive for depressive symptoms with 34%
not working or in school at the time of the interview. Of
interest, amputees reported better scores on the SMFA
compared to limb reconstruction patients as well as lower
rates of post-traumatic stress disorder. Only 17 limb salvage
patients (~10%) in the study underwent revascularization
[11]. These findings are in contrast to LEAP which reported
similar health status measures in amputees and limb salvage
patients, suggesting that translation of findings from
non-combat civilian settings to combat injury may not be
generalizable.
The Late Amputation Study Team (LAST) was to
determine the prevalence of late amputations in
wounded Service members from OEF/OIF/OND. While
most amputations occurred in the acute setting, 15% of
Service members sustaining lower extremity injuries had
late amputations, defined as greater than 12 weeks after
injury, range 12 weeks to 5.5 years [12]. A subset of these
patients with type III open diaphyseal tibia fractures
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increased incidence of infection [13].
Studies examining long term outcomes associated with
vascular interventions are limited
In the Global War on Terror Vascular Initiative (GWOT
VI) Rasmussen and colleagues defined the patterns and
types of injuries [5,14] as well as short term outcomes of
using temporary vascular shunts [6], efficacy of incorpor-
ating endovascular procedures [4], and selective repair of
tibial artery injuries [15]. OEF/OIF/OND vascular trauma
occurred at a 5-times higher rate than previous wars and
was caused predominantly by explosive (73%) and gunshot
(27%) injuries [5]. The increased vascular trauma rate may
be attributable to improvements in body armor, and
increased survivability due to the use of tourniquets and
shorter casualty evacuation times [5]. As a follow up to
the acute care studies, the DoD team initiated a survey
study using the SF-36®, SMFA and a questionnaire to
determine the functional outcomes of Service members
with extremity vascular injury repairs [16]. Long-term
outcomes assessment for this study was limited by
the inability of the DoD team to access VA databases.
Similar to military trauma, multiple reports document
the acute care of patients with civilian vascular extremity
injuries, but limited data on small sample sizes is available
for long-term outcomes [17]. Thirteen of 22 patients
were available with a mean follow-up of 59 months
demonstrating graft patency by duplex ultrasound [17].
Additional studies [18-20] on small numbers of patients
with long term follow up used ankle-brachial indices or
clinical evaluation, which are often inaccurate methods to
assess graft patency [21].
What we know about long-term treatment for patients
following vascular repair is based on vascular repair due
to atherosclerotic disease. Evidence-based treatments
recommended in this patient population include antiplate-
let therapy and duplex ultrasound graft surveillance.
Antiplatelet therapy, especially aspirin, is considered
standard of care for patients with atherosclerotic disease
to prevent death and disability from stroke and myocardial
infarction. Aspirin doses of 80 to 325 mg/day are effective
compared to higher-dose aspirin which can increase
side effects [22]. Multiple studies and reviews have
concentrated on drug therapies to increase patency
rates in extremity vascular bypasses, all focusing on
patients with atherosclerosis. The Antiplatelet Trialists’
Collaboration found that antiplatelet therapy was associ-
ated with a relative risk reduction of 43% in graft occlusion
[23]. However, the optimal therapies that maximize graft
patency and minimize complications may vary depending
on a variety of factors, including whether a venous or pros-
thetic graft is used. The Dutch Bypass Oral Anticoagulant
study (BOA) compared vitamin K antagonists to aspirinand determined that vitamin K antagonists were more
beneficial in patients with vein grafts, albeit with a higher
rate of major bleeding episodes, while aspirin improved
patency in prosthetic grafts [24]. Possible explanations for
these observations include that aspirin may decrease
platelet deposition on the more thrombogenic surface
of prosthetic grafts while the coagulation cascade may
be more critical in vein graft occlusions [25]. Despite
the BOA study, the Seventh American College of
Chest Physicians Conference on Antithrombotic and
Thrombolytic Therapy evidence-based guidelines recom-
mended using aspirin, rather than vitamin K antagonists,
in both venous and prosthetic bypass grafts and the com-
bination of aspirin plus vitamin K antagonists for patients
with a high risk of graft thrombosis and limb loss, noting
that the recommendations placed a high value on the
avoidance of bleeding complications [22]. A Cochrane
review for preventing thrombosis after arterial surgery
concluded that limited evidence suggested antiplatelet
agents such as aspirin, pentoxifylline, or aspirin given with
dipyridamol improved graft patency compared to no treat-
ment. However, patients with prosthetic grafts benefited
more from aspirin or aspirin given with dipyridamol than
patients with venous grafts. For venous grafts, vitamin K
antagonists may be more beneficial and a combination of
aspirin and clopidogrel might be as effective as vitamin K
antagonists [26]. These observations led to the Clopidogrel
and Acetylsalicylic acid in bypass Surgery for Peripheral
Artery disease (CASPAR) trial comparing aspirin plus
clopidogrel to aspirin alone in patients undergoing below
the knee bypasses for peripheral arterial disease. In the
overall population, graft patency was similar in patients
receiving aspirin plus clopidogrel compared to aspirin
alone. However, subgroup analysis revealed an increased
graft patency for aspirin plus clopidogrel in patients re-
ceiving prosthetic grafts without increasing major bleeding
complications [25]. Finally, a systematic review of endo-
vascular therapies found evidence to support the recom-
mendation of aspirin 50 to 300 mg with clopidogrel
possibly being an alternate therapy [27].
Statin use has been associated with increased cardiovas-
cular graft patency, see [28] for recent review. While statins
were associated with improved 1 year survival in patients
receiving lower extremity grafts for atherosclerotic disease,
graft patency was not affected by statin use [29]. Statin use
and graft patency remains an open critical question;
especially given adverse effects (e.g. myopathy) associated
with statin use [30].
Duplex ultrasound graft surveillance is the standard of
care for monitoring bypass grafts and vascular interventions
including vein grafts, angioplasties and/or stents [21,31-34].
This technique allows the physician to visualize the struc-
ture of the blood vessels, how blood is flowing through the
vessels and measures the speed of the flow of blood. Duplex
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blood vessel/graft as well as determine if a stenosis/
occlusion has occurred. This application has been exten-
sively studied in patients with atherosclerosis as the eti-
ology for requiring intervention [21,31-34]. However,
support for use of duplex ultrasound after vascular inter-
ventions performed following traumatic injury is limited
[17]. No information is available regarding the extent to
which this standard of care is met either in the VA or DoD
for vascular repairs performed in trauma patients.
In summary, antiplatelet agents are a mainstay in the
treatment of patients after bypass and endovascular therap-
ies for atherosclerotic disease secondary to their salutary
role in decreasing cardiovascular events and maintaining
graft/endovascular repair patency. Exclusion criteria for
randomized control trials often exclude patients with risk
factors for bleeding; thus, the incidence of complications in
the general population with these treatments may be
different than in the trials. Statin use has been advocated to
improve vascular graft patency; however, prescription
patterns in Veterans with vascular repairs for trauma are
unknown. Duplex ultrasound graft surveillance has also
been used extensively in patients undergoing vascular
repair for atherosclerosis to detect graft failure. Finally,
studies in atherosclerotic patients may not translate to the
predominately younger trauma population and the etiology
of graft failure may be different in trauma patients. Thus,
understanding treatment practices of prescribing antiplatelet
agents and other anticoagulants, and the associated
complications with these treatments, as well the role of
duplex ultrasound, will be a first step in defining the care
of Veterans and civilians with extremity vascular trauma.
Aims of the VA Vascular Injury Study (VAVIS)
VAVIS is a longitudinal cohort study designed to examine
outcomes associated with in-theatre vascular injury, fundedFigure 1 Donabedian’s model of quality of care posits that processes
patient outcomes. However, the complex relationships among demograp
psychiatric conditions require careful attention to the potential for confoun
demographic characteristics, particular concern is focused on controlling fo
substantial impact on the outcome that is unrelated to the initial vascular iby the Department of Veterans Affairs (VA), Health
Services Research and Development Service. Figure 1
shows the theoretical model that guides our research. This
model posits that understanding the health care delivery
process for these injuries will result in a better understand-
ing of their outcomes. Therefore, the goal of VAVIS is to
characterize patients with initial in-theatre limb salvage
(IILS) and identify late vascular surgery related limb
complications in Veterans receiving VA vs. non-VA care.
Because little is known about the natural history of
these types of injuries given modern combat casualty
care, our first aim is to describe the population of interest
including initial and subsequent treatment in the DoD.
Our second aim is to describe extant preventive care
processes provided for individuals with IILS by the VA
since best practices for individuals with traumatic vascular
repair have not been established and little is known about
the types of preventive care available. Because research in
other types of care have found that processes of care
identified as best practices are associated with patient
outcomes [35], our third aim is to identify the association
of Vascular Preventive Care with patient outcomes [36]
such as measures of persistent morbidity, adjusting for
potential confounders, and effect modifiers. While it is
also important to control for demographic characteristics,
particular concern will be focused on controlling for
traumatic brain injury, physical and psychiatric disease
burden, and initial injury characteristics since these may
have substantial impact on the outcome that is unrelated
to the initial vascular injury and preventive care [37]. If
Vascular Preventive Care processes are associated with
positive patient outcomes, there will be support for these
care processes as best practices [38].
Our fourth aim is to describe long-term patient-
reported outcomes in Veterans with traumatic vascular
limb injuries controlling for potential confounders such asof care (Vascular Preventive Care) may be associated with
hic characteristics, initial injury severity, and comorbid physical and
ding and effect modifiers. While it is also important to control for
r disease burden and initial injury characteristics since these may have
njury and preventive care.
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neurological and musculoskeletal components), traumatic
brain injury, and comorbid mental and physical health
conditions. Improvements in battlefield care, such as the
use of temporary vascular shunts, transfusion methods,
etc., have evolved at a very rapid pace, but there is a need
to understand the long-term outcomes of these treatments
to inform clinical decision making and thus fully optimize
trauma systems fielded in-theater. Findings from VAVIS
will provide insight for military trauma, vascular and
orthopedic surgeons to know which types of injuries can
be repaired with adequate functional outcome to justify
the initial surgical decision. It can be a particularly
traumatic and demoralizing experience for a patient
to undergo multiple procedures to attempt limb salvage
only to lose the limb later due to ischemia, infection, exten-
sive musculoskeletal injury or pain. A better understanding
of outcomes will identify which patients may benefit from
initial amputation versus attempts at vascular repair.
Methods/Design
This observational cohort study of Veterans who receive VA
care for IILS will use retrospective data from the DoD and
VA that was collected for the GWOT VI study (DoD) and
the Trajectories of Resilience and Complex Comorbidity
(TRACC [VA]) studies in addition to interview and survey
data collected during the course of this study.
Study sample
Our denominator includes all individuals verified as
having undergone initial in-theatre limb salvage (IILS)
during the GWOT VI study. Inclusion criteria for IILS
included: 1) received a vascular repair on the affected
limb(s) and 2) transferred to the post-anesthesia unit
and to the ICU after surgery. Individuals with ampu-
tations performed as the first, in-theatre operation are
excluded.Figure 2 Eligibility flow diagram showing DoD chart abstractions usinTo date, DoD chart abstractions using the Department
of Defense Trauma Registry (DoDTR) have identified
1,363 individuals with confirmed extremity vascular
injury and initial limb salvage; approximately 1,266 of
these have separated from active service (Figure 2). Based
on VA enrollment data, approximately 59% of OEF/OIF/
OND Veterans discharged from the military have received
VA health care [39], we expect approximately 700
individuals in the VA denominator. Database and
chart abstraction components will include all those
who received VA care (estimated N = 700). Additional
analyses will be conducted for those who do not receive
VA care within limits of available data.
Study procedures
The VAVIS protocol was reviewed and approved by the
VA Central IRB. This three component study will begin
first by compiling data previously collected from DoD
and VA (FY01-FY14), linking files from each source
using the unique identifier. Once VA patients in the
confirmed IILS cohort are identified, we will conduct
medical chart abstraction of VA electronic medical
records, and conduct a patient interview and survey to
obtain patient reported outcomes. The study will start
on April 1, 2015 and will be open for three years.
Previously collected data
Data abstracted from the DoD medical chart in the
GWOT VI study will be used in this study as control
variables, or characteristics for stratification based on
expert consensus of our clinical team. Table 1 provides a
description of the type of information included in the
GWOT VI dataset. These DoD data will be merged with
national VA health care system data collected as part of
the TRACC study (VA inpatient, outpatient, pharmacy
and non-VA care [Fee Basis/ Medicare] data). Table 2
provides a description of the variables, definitions andg the Department of Defense Trauma Registry (DoDTR).
Table 1 Information obtained from DoD chart
abstraction: baseline polytrauma injury characteristics
Type of variable Information
Demographics Age, sex, race/ethnicity and service branch
Initial Injury Information Date, primary cause/mechanism
Vascular Extremity
Details




Associated soft tissue/bone/nerve injuries,
methods of repair, flap status.




Limitations, context of amputation if relevant
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received VA or Medicare care, we will develop variables
related to indicators of persistent morbidity, type of care
received, and long-term outcomes. Table 3 provides a
specific description of these measures and how they
are defined.
VA medical chart abstraction
We will access the electronic medical record for any VA
patient with IILS from the time of VA entry to the time
of abstraction, with special attention to functional outcomes
including physical therapy, prosthetic care, and care for
vascular injuries or conditions such as skin ulcers that may
result from graft failure or complications of the initial
injury. After development of the electronic data collection
template, database, and training, the PI and the chart
abstractors will independently review 10 charts and meet
together to identify inconsistencies, errors, or disagreements
and resolve any by consensus. This will continue until there
is 90% agreement on all items abstracted.
Survey data
After obtaining the appropriate IRB approvals, HIPAA,
and OMB waivers we will proceed with the interview
and survey component using a modification of the
Dillman method [40]. During the chart abstraction
process, we will obtain the contact address for individuals
in the cohort and send a pre-notification letter, which will
include a study information sheet, directions on how to
access the survey online, and a toll-free telephone number
to call to opt out of the survey. Two weeks later we will
call individuals who have not opted out. Research staff will
first obtain verbal consent from the Veteran to proceed
and then will conduct the initial interview that addresses
the Veteran’s understanding of their injury, vascular repair,
and medical care since the original injury. The research
staff will then answer questions regarding completion of
the outcomes survey, which will be offered online or by
mail/telephone options. If the Veteran requests a mailed
survey, the research team will promptly send a packetcontaining the survey, and a stamped envelope for the
participant to return the survey. If the individual requests
telephone survey, research staff will offer the Veteran the
opportunity to complete the survey at that time or to
schedule a time convenient for the Veteran.
For the online/mail survey, one week after the interview,
the research team will send a letter thanking those who
have responded and remind non-respondents to reply,
followed 2 weeks later by a second mailed invitation to
non-respondents to complete the on-line survey (or mailed
back-up). We will provide a gift card to participants who
complete the mailed surveys.
The primary survey outcome measure for this study is
one used for the GWOT VI: the Short Musculoskeletal
Function Assessment. Additional instruments include the
Paffenbarger Physical Activity Questionnaire, Chronic Pain
Grade Scale, and the Military to Civilian Questionnaire
MC2-Q (a measure of community re-integration). Short
Musculoskeletal Function Assessment (SMFA) is a validated,
46-item self-reported health status questionnaire on
extremity functional status. The SMFA contains two parts:
the dysfunction index and the quality-of-life limitation
index. The SMFA questionnaire has excellent internal
consistency and stability, with most values greater than
0.90. Content validity for the dysfunction and bother
indexes was supported with few ceiling effects (less than 5
percent), and no floor effects. Moreover, significant
correlations were found between the SMFA dysfunction
and other indexes and the physicians’ ratings of patient
function (e.g., recreational and leisure activities, activities
of daily living, and emotional function [rho ≥ 0.40]) and
clinical measures including grip strength and walking
speed [rho ≥ 0.40] [41].
The Paffenbarger Physical Activity Questionnaire [42]
(PPAQ) is a validated scale that describes participation
in physical activity more specific to sports and leisure
which has been used in a number of prior studies
including the METALS study [11]. This instrument asks
respondents to identify up to 4 activities performed in
the past three months, the amount of time spent in
those activities, and the intensity of those activities. This
instrument allows a calculation of the approximate
metabolic equivalents (METS) expended (e.g. an adult
sitting quietly expends 1 MET). We will use Ainsworth’s
Compendium of Physical Activities [43] to classify reported
activity by the rate of expended energy into METS in the
same manner used by the METALS study to improve
comparability to findings.
The Chronic Pain Grade (CPG) scale [44] is a vali-
dated measure of the severity of chronic pain. Similar
to the METALS study, we will use the pain interfer-
ence questions to distinguish the extent to which physical
function and activities of daily living are affected by the
pain [11].
Table 2 Data variables, definitions, and data sources
Variables How defined Data source
Demographic Characteristics Age, Sex, Race/ Ethnicity, Education OEF/OIF/OND Roster File (from Environmental
Epidemiology Service)
Military Characteristics Rank, Component (active, guard,
reserve), Service Branch,
Military Discharge Date Military discharge dates
Other Demographic Characteristics Marital status National VA Inpatient and Outpatient Care Files
(Medical SAS data sets)
Diagnoses for which care is received ICD-9-CM Codes each visit
Location of Care/ Facility Type (e.g. Medical Center,
outpatient clinic, community based outpatient clinic)
STA5A/STA6A; Last letter of code
indicates the type of facility
Type of care: Relevant specialty care: vascular surgery
clinic (415), vascular lab (421), amputation clinic (418),
prosthetic clinic (417), PM&R (201,211).
DSS Identifier (stop code)
Procedures: tests such as duplex ultrasound or type
of surgery when admission is on day of surgery
CPT-4 Codes
Geospatial data of patient home to identify distance




Diagnoses for which care is received ICD-9-CM Codes each visit National VA Inpatient Care Files (Medical SAS
data sets from national repository at the Austin
Automation Center)
Location of Care/ Facility Type (e.g. Medical Center,
domiciliary, neuro/psychiatric hospital)
STA5A
Provider Specialty: Bedsection is mapped 1:1 with
provider specialty (e.g., vascular [106] and peripheral
vascular [62].
Bedsection
Procedures: tests such as duplex ultrasound or type of
surgery
ICD-9A Codes
Geospatial (same as above) Zip Code, Longitude/latitude
patient home
Medications Prescribed (e.g., opioids, other
medications for pain, antibiotics for persistent
infections such as osteomyelitis, antiplatelet a
gents, statins)
VA Product name, strength,
day supply, number of pills
dispensed Medicare Part D
National Drug Code (NDC)
National Pharmacy Files from the Pharmacy Benefits
Management Strategic health Group, Medicare Part D
Dose of medications average monthly dose
(dose per unit × day supply)
Generic, day supply, number
of units, dose, Medicare
Part D: NDC code
Duration of use Day supply summed over time
Specific Prosthetic Device HCPCS PSAS, HCPCS CPT codes
identify the specific item
National Prosthetics Patient Database (NPPD)
Specific Service Connected Disability and %
disability for each condition
VETSNET condition code, %,
number of disabling condition,
service connected disability indicator
Veterans Service Network (VETSNET) Corporate Mini
Master File (VETSNET File) derived from the Veterans
Benefits Administration (VBA) Corporate Database.
Pain Scores: longitudinally (1–10 each visit) Pain score Corporate Data Warehouse
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the basis of empirical studies linking each questionnaire
item to a comprehensive “pool” of widely used question-
naire items, including but not limited to the SF-36®, proven
to measure the same health concepts. Because the item
“pool” for each of the eight health concepts was calibrated
on the same metric as the corresponding SF-36® Health
Survey scale, each SF-8™ single-item scale and the SF-8™
summary measures can be scored on the same norm-basedmetrics as the SF-36® scales and summary measures. Thus,
the SF-8™ is an 8-item version of the SF-36® that yields a
comparable 8-dimension health profile and comparable
estimates of summary scores for the physical and mental
components of health [45]. Therefore, we will use the
SF-8™ rather than the SF-36™.
The Military to Civilian Questionnaire is a validated,
16 item self-reported measure of experiences during
military to civilian transition, developed by Sayer and
Table 3 Indicators of persistent morbidity
Indicators of persistent morbidity Data used to identify Data source
Use of unscheduled or emergency care for vascular issues DSS Clinic Identifier and ICD-9 Codes Outpatient (OPC) files; VA-CMS
Use of scheduled care for polytrauma vascular issues DSS Clinic Identifier and ICD-9 Codes OPC files; VA-CMS
Long-term use/escalating dose of opioid medications VA Product, Dose, Day Supply Pharmacy Benefits Management
(PBM) Data; Medicare Part D VA-CMS
NDC Code
Trajectory of chronic pain (latent class analysis of pain
scores from TRACC)
Pain Score CDW vitals
Conditions indicative of persistent morbidity (e.g., Venous
stasis disease/venous ulcers, lymphedema)
ICD-9 Codes including but not limited to
729.81, 782.3, 729.5, 415.19, 451.11, 451.19
451.83, 451.82, V72.83
PTF, OPC files, VA-CMS
Prescriptions for compression stockings and wound care
supplies (e.g., wound vac) indicative of swelling, venous
stasis disease
VA Class PBM Data, VA-CMS Durable Medical
Equipment
XA
Use of prosthetic/orthotic devices (canes, walkers, special
shoes, etc).
Health Care Financing Administration
Coding System (HCPCS) Prosthetic and
Sensory Aids Service (PSAS) Code;
National Prosthetics database
CMS Durable Medical Equipment
Additional procedures (open or endovascular) on the injured
extremity
CPT-4; ICD-9A procedure codes OPC/PTF VA-CMS
Chronic antibody use (osteo or other potential infectious
issues with the limb)
VA Product PBM Data; Medicare Part D VA-CMS
Duplex ultrasound, MRA/CTA or angiogram to evaluate the repair CPT-4 procedure codes including but
not limited to 93970, 93971, 93975, 93976,
93978, 93979, 93922, 93923, 93925, 93926,
93930, 93931, 93924
OPC/PTF; VA-CMS
Mean pain scores over 4 Pain Score Mean per year Corporate data warehouse Vital Signs
Proportion of VA care Visits VA/ Total Visits OPC/PTF; VA CMS outpatient/inpatient
Mortality Date of Death VA Vital Status file
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[46]. It was validated using a, stratified sample of 1,226
Iraq and Afghanistan Veterans who used VA medical
care. The internal consistency of the M2C-Q was .95 in
this sample. Factor analyses indicated a single total score
was the best-fitting model. Total scores were associated
with measures theoretically related to reintegration difficul-
ties including perception of overall difficulty readjusting
back into civilian life (R2 = .49), probable PTSD, probable
problem drug or alcohol use, and overall mental health.
Subgroup analyses revealed a similar pattern of findings in
those who screened negative for PTSD.
In addition to these outcome variables, we will collect
self-reported behavioral health symptoms.
Depression Severity will be assessed with the Center
for Epidemiologic Studies Short Depression Scale
(CES-D 10), which has been demonstrated to be a
valid and reliable measure to assess depression in
both VA and non-VA settings [47-49]. The 10 items
are rated on a 0 (rarely or none of the time) to 3 (all
of the time) scale. Items for this instrument have not
been directly mapped onto the 9 DSM IV diagnostic
criteria for Major Depression, but the sensitivity and
specificity average 80% and 70% respectively with regard
to results from a formal diagnostic interview [47,48].PTSD Severity will be assessed with the PTSD Checklist-
Military (PCL-M) [50]. The PTSD Checklist is a 17-item
self-report measure designed to assess the diagnostic
criteria of re-experiencing, avoidance and numbing, and
hyperarousal. Respondents indicate on a 5-point scale
(“Not at all” to “A great deal”) how much they were
bothered by each symptom in the past month.
Other data for spatial analysis
Research staff will contact vascular surgery, surgery, and
physical medicine and rehabilitation clinics at each VA
hospital to determine the extent to which VA facilities
use contracts for vascular surgery patients and will
identify sites with external contracts for vascular surgery,
rehabilitation medicine and prosthetics care to create a
data set to be used in our spatial analysis.
Analytic plan
To address the first aim, we will compare injury, demo-
graphic and geospatial characteristics of patients IILS and
identify late vascular surgery related limb complications
and health care utilization in Veterans receiving VA vs.
non-VA care using merged VA +VA-Medicare and DoD
study data. We will identify vascular procedures performed,
limb salvage survival time, and indicators of persistent
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vascular-related conditions, venous stasis disease, prosthetic
use, long-term opioid therapy [VA patients only]). We will
calculate descriptive statistics for all IILS patients’ demo-
graphic characteristics, long-term clinical outcomes
(surgery related limb complications, time to amputation,
persistent morbidity), and healthcare utilization (note that
long-term use of opioid therapy will be assessed only
among VA patients). We will also compare these descriptive
statistics between those who received VA vs. non-VA care
using chi-square tests for categorical variables and t-tests
for continuous variables (with appropriate Box-Cox power
transformation if necessary).
To address the second aim, characterize the preventive
services received by individuals with vascular repair and
related outcomes, we will first compute the proportion
of patients who receive antiplatelet agents, statins,
annual duplex ultrasound, and vascular specialty care
(and categories described above), and the percent
patency each year for individuals without amputation.
We will then examine the relationship between percent
patency and preventive care using random effects
analyses that models the vascular repair patency as a
linear function of the indicator of receiving antiplatelet
agents, statins, duplex ultrasound [51,52], and other
covariates/confounders (e.g., number of limbs affected,
any initial, early or late amputations, mental health
comorbidity, TBI diagnosis, and pre-existing chronic
disease states such as atherosclerosis, diabetes, peptic
ulcer disease), where the random effect is used to adjust
for the within facility correlation, and the inverse of the
propensity score for receiving antiplatelet agents/statins/
yearly duplex ultrasound is adjusted for as weights.
The adjustment of the propensity score for receiving
antiplatelet agents/statins/yearly duplex ultrasound
will minimize the estimation biases due to confounding by
indication. We will also create different cut points (e.g.
75%, 50% patent), and use a binary outcome model. If
Vascular Preventive Care processes are associated with
positive patient outcomes, there will be support for these
care processes as best practices.
We will also conduct generalizability analysis using the
inverse propensity probability weight technique. [53,54]
The goal is to examine whether the outcome model
derived from the VA IILS patients (as described above)
can be generalized to the non-VA IILS patients. We first
derive model estimates for the VA cohort, then compute
the propensity score for receiving non-VA care by
modeling the log-odds of receiving non-VA care (vs. VA
care) as a linear function of baseline covariates. The inverse
propensity weighting is used to calibrate the outcome
model derived from the VA IILS patients to the non-VA
IILS patients. Finally we assess model generalizability by
comparing model estimates between the VA vs. non-VApatients using the diagnostic method by Stuart et al. [55]
This generalizability method does not require collecting
outcomes for non-VA patients. However the credibility of
this method relies on the “ignorability” assumption to hold
true: conditioning on the covariates, the counterfactual
outcomes of the non-VA patients (the patency outcomes
should they receive VA care) would have been the same as
the outcomes of the VA patients, and similarly, the counter-
factual outcomes of the VA patients (the patency outcomes
should they receive non-VA care) would have been the
same as the outcomes of the non-VA patients.
Based on preliminary data from the TRACC study, we
anticipate that the proportion of OEF/OIF/OND VA
patients with ILLS will receive antiplatelet agents/statins/
or yearly duplex ultrasound will be no greater than 44.7%.
We also assume that the mean vascular repair patency
falls between 50%-60%, and that the increased patency
due to receiving antiplatelet agents/statins/or yearly
duplex ultrasound is no less than 12% (conservatively).
Under these conditions, the study will have ≥0.84 power
to determine if Vascular Preventive Care processes are
associated with positive patient outcomes.
To address the third aim (Describe patient-reported
functional outcomes in Veterans with traumatic vascular
limb injuries) we will begin by examining descriptive
statistics associated with SMFA, PPFA, CPG scale, SF-8™,
and M2C-Q). We will compare scores on these instru-
ment among IILS patients with and without indicators of
persistent morbidity, controlling for possible confounders
associated with having indicators of persistent morbidity
(from Aim 1) including CES-D, and PCL-M. We will then
conduct separate generalized estimation equation analyses
for each outcome, modeling the mean of each outcome
as a linear function of the indicator of having one or
more indicators of persistent morbidity and other
covariates [52].
Secondary analyses will stratify individuals by initial injury
severity type (e.g., vascular only, vascular + orthopaedic,
vascular + orthopaedic + nerve, etc.) to further control for
initial conditions that may be more difficult to control for
in multivariable analyses. We will also examine the role of
various prosthetic devices, including the extent to which
the technology of the device, the number of different
prosthetic devices per limb, etc. mediate the relationship
between injury severity, persistent morbidity and functional
outcomes. Furthermore, we will conduct generalizability
analysis (described above) to examine whether the outcome
model derived from the VA patients can be generalized to
the non-VA patients.
Our power analysis for the third aim is based on the
primary outcome: SMFA. Based on preliminary data, we
assume that the proportion of patients with persistent
morbidity falls between 10% and 50%. We also assume
that the effect size associated with persistent morbidity
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than 0.435. Under those conditions, the study will have
>0.80 power to identify a true difference in outcomes
among those with and without persistent morbidity.
Discussion
This study will provide key information about the
current process of care for OEF/OIF/OND Veterans
with polytrauma/vascular injuries at risk for persistent
morbidity and late amputation. The results of this study
will be the first step for clinicians in VA and military
settings to generate evidence-based treatment and care
approaches to these injuries. It will identify areas where
rehabilitation medicine and vascular specialty care or
telehealth options are needed allowing for better planning,
resource utilization, and improved DoD-to-VA care
transitions. Using the DoDTR to identify injured Service
members and a DoD-VA research team to determine the
long term outcome of traumatic vascular injury repairs
provides an unprecedented opportunity to define current
processes of care and improve the evidence base for
further treatment. In addition, methods used in VAVIS
can be applied to other health care problems encountered
in combat casualty care to determine long term outcomes.
These studies have the potential to improve battlefield
care, transitions of care between the DoD and VA, as well
as to determine care teams within the VA to optimally
treat these complex patients.
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